4.6 Review

Host-directed therapies in pulmonary tuberculosis: Updates on anti-inflammatory drugs

Related references

Note: Only part of the references are listed.
Review Hematology

The Dark Side of the COVID-19 Treatments on Mycobacterium tuberculosis Infection

Flavio De Maio et al.

Summary: Since the emergence of SARS-CoV-2, various medications have been used to treat COVID-19. Targeting the host immune response has been a promising strategy, and this article summarizes the treatments and their potential effects on Mtb infection.

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2022)

Review Respiratory System

COVID-19 and tuberculosis: the double whammy of respiratory pathogens

Mohd Shariq et al.

Summary: The COVID-19 pandemic has had a severe impact on tuberculosis (TB) elimination programs, leading to a decrease in TB case notifications and immunizations. The clinical characteristics of TB and COVID-19 are similar, with immune dysregulation being a factor in both diseases. It is important to manage and combat the syndemic of TB and COVID-19.

EUROPEAN RESPIRATORY REVIEW (2022)

Review Immunology

Host-directed therapy to combat mycobacterial infections*

Gul Kilinc et al.

Summary: This article discusses the host responses to mycobacterial infection and the mechanisms that affect bacterial killing, introducing the advantages of host-directed therapy (HDT). It focuses on the potential applications of HDT for both tuberculosis and nontuberculous mycobacteria, as well as future research directions.

IMMUNOLOGICAL REVIEWS (2021)

Article Immunology

Adjunct N-Acetylcysteine Treatment in Hospitalized Patients With HIV-Associated Tuberculosis Dampens the Oxidative Stress in Peripheral Blood: Results From the RIPENACTB Study Trial

Izabella P. Safe et al.

Summary: NAC as a precursor of GSH can improve antioxidant status and reduce lipid peroxidation during TB treatment, with minimal impact on cytokine concentrations.

FRONTIERS IN IMMUNOLOGY (2021)

Review Immunology

One Size Fits All? Not in In Vivo Modeling of Tuberculosis Chemotherapeutics

Hee-Jeong Yang et al.

Summary: Tuberculosis remains a global health problem due to issues such as lack of diagnosis and incomplete treatment, as well as drug-resistant strains of Mycobacterium tuberculosis. The development of new drugs for TB has accelerated in recent years, with a focus on addressing resistance and shortening treatment duration. Animal models are essential for predicting drug efficacy and studying disease pathology, with a variety of models offering insights into bacterial burden and lesion-specific drug concentrations. Incorporating medical imaging and drug distribution measurements in animal models is crucial for advancing drug development and improving treatment regimens.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Article Critical Care Medicine

Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial

Robert S. Wallis et al.

Summary: This study conducted a phase 2 clinical trial in South Africa to evaluate the safety and preliminary efficacy of four host-directed therapies for tuberculosis. The results showed that CC-11050 and everolimus as adjunctive therapies have the potential benefits for tuberculosis patients, increasing the recovery of FEV1.

LANCET RESPIRATORY MEDICINE (2021)

Article Medicine, Research & Experimental

Doxycycline host-directed therapy in human pulmonary tuberculosis

Qing Hao Miow et al.

Summary: The study demonstrated the pathological inhibition effect of doxycycline on matrix metalloproteinases (MMPs) in patients with pulmonary tuberculosis, and it could accelerate the restoration of gene expression. Doxycycline not only reduced the levels of MMPs in sputum of tuberculosis patients, but also inhibited the destruction of collagen and elastin, showing significant differences compared to placebo.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Pharmacology & Pharmacy

Opposite effects of statins on the risk of tuberculosis and herpes zoster in patients with diabetes: A population-based cohort study

Sheng-Wei Pan et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)

Review Immunology

Therapeutic host-directed strategies to improve outcome in tuberculosis

C. Young et al.

MUCOSAL IMMUNOLOGY (2020)

Review Integrative & Complementary Medicine

Effectiveness of micronutrients supplement in patients with active tuberculosis on treatment: Systematic review/Meta-analysis

Betty Katherin Cabrera Andrade et al.

COMPLEMENTARY THERAPIES IN MEDICINE (2020)

Review Oncology

Effects of host-directed therapies on the pathology of tuberculosis

Liana Tsenova et al.

JOURNAL OF PATHOLOGY (2020)

Review Immunology

Host-Pathogen Interaction as a Novel Target for Host-Directed Therapies in Tuberculosis

Rodrigo Abreu et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Immunology

Host-Directed Therapy in Tuberculosis: Targeting Host Metabolism

Jae-Sung Kim et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Nutrition & Dietetics

Immunologic Effects of Vitamin D on Human Health and Disease

Nipith Charoenngam et al.

NUTRIENTS (2020)

Article Multidisciplinary Sciences

Metformin enhances anti-mycobacterial responses by educating CD8+T-cell immunometabolic circuits

Julia Boehme et al.

NATURE COMMUNICATIONS (2020)

Review Health Policy & Services

Treatment outcomes of extrapulmonary tuberculosis in Bahawalpur, Pakistan; a record review

Muhammad Atif et al.

JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE (2020)

Review Immunology

Understanding the early host immune response against Mycobacterium tuberculosis

Babban Jee

CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2020)

Review Medicine, General & Internal

Anti-tuberculous Effects of Stain Therapy: A Review of Literature

Faryal Tahir et al.

CUREUS JOURNAL OF MEDICAL SCIENCE (2020)

Article Health Care Sciences & Services

Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis

Adrian R Martineau et al.

HEALTH TECHNOLOGY ASSESSMENT (2019)

Review Biochemistry & Molecular Biology

Matrix Metalloproteinases in Pulmonary and Central Nervous System Tuberculosis-A Review

Ursula K. Rohlwink et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Medicine, General & Internal

Use of Antiplatelet Agents and Survival of Tuberculosis Patients: A Population-Based Cohort Study

Meng-Rui Lee et al.

JOURNAL OF CLINICAL MEDICINE (2019)

Article Infectious Diseases

Treatment outcomes and risk factors of extra-pulmonary tuberculosis in patients with co-morbidities

Amer Hayat Khan et al.

BMC INFECTIOUS DISEASES (2019)

Article Microbiology

Simvastatin Enhances the Immune Response Against Mycobacterium tuberculosis

Paola Del Carmen Guerra-De-Blas et al.

FRONTIERS IN MICROBIOLOGY (2019)

Review Pediatrics

Immune Response to Mycobacterium tuberculosis: A Narrative Review

Maurizio de Martino et al.

FRONTIERS IN PEDIATRICS (2019)

Review Immunology

Remembering the Host in Tuberculosis Drug Development

Daniel J. Frank et al.

JOURNAL OF INFECTIOUS DISEASES (2019)

Review Biotechnology & Applied Microbiology

Host-directed therapies for bacterial and viral infections

Stefan H. E. Kaufmann et al.

NATURE REVIEWS DRUG DISCOVERY (2018)

Article Critical Care Medicine

Platelets Regulate Pulmonary Inflammation and Tissue Destruction in Tuberculosis

Katharine A. Fox et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)

Review Endocrinology & Metabolism

Vitamin D: Classic and Novel Actions

Angel Gil et al.

ANNALS OF NUTRITION AND METABOLISM (2018)

Article Infectious Diseases

Metformin reduces the relapse rate of tuberculosis patients with diabetes mellitus: experiences from 3-year follow-up

Y. Ma et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2018)

Review Biochemistry & Molecular Biology

Narrow-spectrum antibacterial agents

Roberta J. Melander et al.

MEDCHEMCOMM (2018)

Article Medicine, General & Internal

The effect of metformin on culture conversion in tuberculosis patients with diabetes mellitus

Ye-Jin Lee et al.

KOREAN JOURNAL OF INTERNAL MEDICINE (2018)

Article Immunology

A Beneficial Effect of Low-Dose Aspirin in a Murine Model of Active Tuberculosis

Vera Marie Kroesen et al.

FRONTIERS IN IMMUNOLOGY (2018)

Review Respiratory System

New drugs and perspectives for new anti-tuberculosis regimens

S. Tiberi et al.

PULMONOLOGY (2018)

Review Food Science & Technology

The vicious cycle of vitamin a deficiency: A review

Elina Manusevich Wiseman et al.

CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2017)

Article Biochemistry & Molecular Biology

VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors

F. Roehrig et al.

ONCOGENE (2017)

Review Immunology

Strategies to improve vaccine efficacy against Tuberculosis by Targeting innate immunity

Ulrich E. Schaible et al.

FRONTIERS IN IMMUNOLOGY (2017)

Review Medicine, General & Internal

Host-Directed Therapeutic Strategies for Tuberculosis

Afsal Kolloli et al.

FRONTIERS IN MEDICINE (2017)

Article Critical Care Medicine

High-Dose Vitamin D3 during Tuberculosis Treatment in Mongolia A Randomized Controlled Trial

Davaasambuu Ganmaa et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)

Article Critical Care Medicine

Statin Use Is Associated With a Lower Risk of TB

Vincent Yi-Fong Su et al.

CHEST (2017)

Article Public, Environmental & Occupational Health

Vitamin D deficiency among newly diagnosed tuberculosis patients and their household contacts: a comparative cross-sectional study

Meseret Workineh et al.

ARCHIVES OF PUBLIC HEALTH (2017)

Article Infectious Diseases

Statin adjunctive therapy shortens the duration of TB treatment in mice

Noton K. Dutta et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)

Article Medicine, General & Internal

Tuberculosis

Madhukar Pai et al.

NATURE REVIEWS DISEASE PRIMERS (2016)

Review Medicine, General & Internal

Nutritional supplements for people being treated for active tuberculosis

Liesl Grobler et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)

Article Nutrition & Dietetics

High-dose vitamin D3 in adults with pulmonary tuberculosis: a double-blind randomized controlled trial

Nestan Tukvadze et al.

AMERICAN JOURNAL OF CLINICAL NUTRITION (2015)

Review Pharmacology & Pharmacy

Vitamin D: Immuno-modulation and tuberculosis treatment

Paramasivam Selvaraj et al.

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2015)

Review Medicine, General & Internal

Inflammation and tuberculosis: host-directed therapies

A. Zumla et al.

JOURNAL OF INTERNAL MEDICINE (2015)

Article Immunology

Advancing host-directed therapy for tuberculosis

Robert S. Wallis et al.

NATURE REVIEWS IMMUNOLOGY (2015)

Article Critical Care Medicine

Tuberculosis, Pulmonary Cavitation, and Matrix Metalloproteinases

Catherine W. M. Ong et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)

Article Microbiology

Statins Increase Rifampin Mycobactericidal Effect

Livia Silva Lobato et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)

Review Respiratory System

Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis

Noor Alsaad et al.

EUROPEAN RESPIRATORY JOURNAL (2014)

Article Infectious Diseases

Change in serum CXCL10 levels during anti-tuberculosis treatment depends on vitamin D status

Z. Hasan et al.

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2014)

Article Infectious Diseases

Simvastatin increases the in vivo activity of the first-line tuberculosis regimen

Ciaran Skerry et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)

Article Multidisciplinary Sciences

Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk

Katrin D. Mayer-Barber et al.

NATURE (2014)

Article Cell Biology

Metformin as adjunct antituberculosis therapy

Amit Singhal et al.

SCIENCE TRANSLATIONAL MEDICINE (2014)

Review Infectious Diseases

Extrapulmonary tuberculosis: are statistical reports accurate?

Ekaterina Kulchavenya

THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE (2014)

Editorial Material Immunology

Nonsteroidal Antiinflammatory Drugs for Adjunctive Tuberculosis Treatment

Juraj Ivanyi et al.

JOURNAL OF INFECTIOUS DISEASES (2013)

Article Multidisciplinary Sciences

Induced Sputum MMP-1,-3 &-8 Concentrations during Treatment of Tuberculosis

Cesar A. Ugarte-Gil et al.

PLOS ONE (2013)

Review Multidisciplinary Sciences

Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?

Lisa M. Coussens et al.

SCIENCE (2013)

Article Critical Care Medicine

Doxycycline and HIV Infection Suppress Tuberculosis-induced Matrix Metalloproteinases

Naomi F. Walker et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)

Review Immunology

The Tuberculous Granuloma: An Unsuccessful Host Defence Mechanism Providing a Safety Shelter for the Bacteria?

Mayra Silva Miranda et al.

CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)

Review Respiratory System

N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease

Anna M. Sadowska

THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2012)

Editorial Material Medicine, Research & Experimental

MMPs in tuberculosis: granuloma creators and tissue destroyers

Padmini Salgame

JOURNAL OF CLINICAL INVESTIGATION (2011)

Review Biochemistry & Molecular Biology

IL-17 and Th17 cells in tuberculosis

Egidio Torrado et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2010)

Article Gastroenterology & Hepatology

Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity

Shadi Baniasadi et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)

Article Clinical Neurology

Role of aspirin in tuberculous meningitis: A randomized open label placebo controlled trial

U. K. Misra et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)

Article Public, Environmental & Occupational Health

Trends in Tuberculosis Mortality in the United States, 1990-2006: A Population-Based Case-Control Study

Richard S. Jung et al.

PUBLIC HEALTH REPORTS (2010)

Review Microbiology

New Drugs against Tuberculosis: Problems, Progress, and Evaluation of Agents in Clinical Development

Jossy van den Boogaard et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)

Article Pharmacology & Pharmacy

Impact of Infectious and Inflammatory Disease on Cytochrome P450-Mediated Drug Metabolism and Pharmacokinetics

E. T. Morgan

CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)

Article Microbiology

Mycobacterium tuberculosis Is Able To Accumulate and Utilize Cholesterol

Anna Brzostek et al.

JOURNAL OF BACTERIOLOGY (2009)

Article Immunology

Vitamin D-Directed Rheostatic Regulation of Monocyte Antibacterial Responses

John S. Adams et al.

JOURNAL OF IMMUNOLOGY (2009)

Article Multidisciplinary Sciences

Mycobacterial persistance requires the utilization of host cholesterol

Amit K. Pandey et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Medicine, General & Internal

Trends in tuberculosis/human immunodeficiency virus comorbidity, United States, 1993-2004

Rachel Albalak et al.

ARCHIVES OF INTERNAL MEDICINE (2007)

Article Immunology

Coagulant and fibrinolytic status in tuberculous meningitis

Johan Schoeman et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2007)

Article Infectious Diseases

Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis

Sean T. Byrne et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)

Review Immunology

Matrix metalloproteinases as modulators of inflammation and innate immunity

WC Parks et al.

NATURE REVIEWS IMMUNOLOGY (2004)

Article Clinical Neurology

Persistent increase of matrix metalloproteinases in cerebrospinal fluid of tuberculous meningitis

KY Lee et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2004)

Review Respiratory System

Matrix metalloproteinases in lung biology

WC Parks et al.

RESPIRATORY RESEARCH (2001)